Results 41 to 50 of about 31,037 (228)
Cannabidiol in the Treatment of Epilepsy [PDF]
Clinical Drug Investigation, 2021 Anecdotal reports addressing the successful seizure treatment of severe epilepsies with cannabidiol (CBD) have increased both public interest and academic research. Placebo-controlled, randomized, controlled trials proved the efficacy of pharmaceutical-grade CBD in epilepsy treatment, thus leading to pharmaceutical-grade CBD approval by the US Food and
von Wrede, Randi +2 more
openaire +2 more sources
The Lancet Regional Health. Europe, 2023 Summary: Background: Painful knee osteoarthritis (KOA) is common, pharmacological treatment, however, is often hampered by limited tolerability. Cannabidiol, which preclinically showed anti-inflammatory, analgesic activity, could supplement established ...
Sibylle Pramhas +6 more
doaj +1 more source
Analyzing cannabinoid-induced abnormal behavior in a zebrafish model.
PLoS ONE, 2020 In this study, we investigated locomotor activity and responses to repeated light and dark stimuli to assess cannabinoid-induced abnormal behavior in zebrafish larvae (Danio rerio), as an alternative to standard rodent models.
Akihiro Hasumi +2 more
doaj +1 more source
Passive exposure to cannabidiol oil does not cause microbiome dysbiosis in larval zebrafish
Current Research in Microbial Sciences, 2021 The use of cannabidiol oil derived products has dramatically increased in popularity and is predicted to grow steadily over the next decade. Given its relative stability, cannabidiol is likely to accumulate in the environment and affect aquatic animals ...
Maracela Talamantes +3 more
doaj +1 more source
, 2022 Gramicidin current measurements in high [140 mM] and low [1 mM] sodium (Na+) in extracellular HEK cell membrane. This data accompanies the the submitted manuscript "Data for Cannabidiol Increases Gramicidin Current in Human Embryonic Kidney Cells: An ...
Ghovanloo, Mohammad-Reza +2 more
core
Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients
Medical Cannabis and Cannabinoids, 2023 Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome.
Edward Y. Liu +2 more
doaj +1 more source
Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis [PDF]
International Journal of Minor Fruits, Medicinal and Aromatic PlantsThe purpose of this study was to characterize the key patterns of cannabidiol metabolism and elimination. To fulfil this purpose, the study employed the latest scientific sources for the last 5-6 years from authoritative scientometric databases and ...
Oles-Pylyp Hasiuk
doaj +1 more source
Iowa School Medical Cannabidiol Guidance, March 8, 2022 [PDF]
, 2022 School districts adopt policies to implement a drug-free workplace under the Drug-Free Work Act (41 U.S.C. 81). An employee who is using cannabidiol that is covered in the Iowa Medical Cannabidiol Act is not protected from violating school district ...
core
Frontiers in Molecular Neuroscience, 2021 Cannabidiol, a compound of Cannabis sativa, has been proposed as an alternative treatment of schizophrenia. Preclinical and clinical data have suggested that cannabidiol shares more similarity with atypical antipsychotics than typical, both of which are ...
Ana Caroline Brambilla Falvella +12 more
doaj +1 more source